We are live on ! Find out more
MM

MWG Management Portfolio holdings

AUM $81.3M
1-Year Est. Return 2.28%
This Fund
S&P 500
This Quarter Est. Return
+3.95%
1 Year Est. Return
+2.28%
3 Year Est. Return
-59.16%
5 Year Est. Return
-10.97%
10 Year Est. Return
AUM
$222M
AUM Growth
-$14M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYEL icon
1
Lyell Immunopharma
LYEL
$321M
$131M 59.13%
1,008,117
BEAM icon
2
Beam Therapeutics
BEAM
$2.81B
$90.8M 40.87%
2,346,934

Similar funds

MWG Management's Q2 2022 Portfolio in Review

As of Q2 2022, MWG Management held 2 positions worth $222M, down 5.9% from $236M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. MWG Management opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MWG Management's ten largest holdings make up 100% of its $222M portfolio in Q2 2022.
  • MWG Management opened 0 new positions and closed 0 in Q2 2022.
  • MWG Management's portfolio value fell 5.9% quarter-over-quarter to $222M.

Based on MWG Management's 13F filing for Q2 2022, filed 15 Aug 2022.